| SYS | | r022952 |
|---|
| LBL | | ^^^^^naa^^22^^^^^^^^450^ |
|---|
| 005 | | 20130617140415.3 |
|---|
| 100 | | $a 20030911a2003 m y0sloc0103 ba |
|---|
| 101 | 0- | $a eng $d eng |
|---|
| 102 | | $a SK |
|---|
| 200 | 1- | $a Prevalence and prognostic value of c-erbB2 expression in non-small cell lung cancer (NSCLC) $f O. Turken ... [et al.] |
|---|
| 215 | | $c Obr., tab. |
|---|
| 320 | | $a Res. angl. |
|---|
| 320 | | $a Bibliogr. odkazy |
|---|
| 463 | -1 | $1 001 sllk_un_cat*sg000148_2003_003_004 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 50, no. 4 (2003), s. 257-261 $1 210 $a Bratislava $c Veda |
|---|
| 541 | 1- | $a Prevalencia a prognostická hodnota expresie c-erbB2 pri nemalobunkovom pľúcnom karcinóme |
|---|
| 606 | 1- | $a karcinóm pľúc, nemalobunkový $x komplikácie $2 mesh $3 sllk_un_auth*d002289 $9 . |
|---|
| 606 | 1- | $a receptor erbB-2 $x analýza $x genetika $2 mesh $3 sllk_un_auth*d018719 $9 . |
|---|
| 606 | 1- | $a prevalencia $2 mesh $3 sllk_un_auth*d015995 $9 . |
|---|
| 606 | 2- | $a prognóza $2 mesh $3 sllk_un_auth*d011379 $9 . |
|---|
| 606 | 2- | $a imunohistochémia $x metódy $2 mesh $3 sllk_un_auth*d007150 $9 . |
|---|
| 606 | 2- | $a farmakoterapia $2 mesh $3 sllk_un_auth*d004358 $9 . |
|---|
| 675 | | $a 616.24-006.6:575.113 $v 2. $z slo |
|---|
| 701 | -1 | $a Turken $b O. $3 sllk_un_auth*p0032311 $4 070 $p Department of medical oncology, GATA Haydarpasa training hospital, Istanbul, Turkey |
|---|
| 702 | -1 | $a Kunter $b E. $3 sllk_un_auth*p0032312 $4 070 $p Department of chest diseases, GATA Haydarpasa training hospital, Istanbul, Turkey |
|---|
| 702 | -1 | $a Cermik $b H. $3 sllk_un_auth*p0032313 $4 070 $p Department of pathology, GATA Camlica chest diseases hospital, Istanbul, Turkey |
|---|
| 702 | -1 | $a Isitmangil $b T. $3 sllk_un_auth*p0032314 $4 070 $p Department of thoracic surgery, GATA Haydarpasa training hospital, Istanbul, Turkey |
|---|
| 702 | -1 | $a Kandemir $b G. $3 sllk_un_auth*p0032316 $4 070 $p Department of medical oncology, GATA Haydarpasa training hospital, Istanbul, Turkey |
|---|
| 702 | -1 | $a Yaylaci $b M. $3 sllk_un_auth*p0032317 $4 070 $p Department of medical oncology, GATA Haydarpasa training hospital, Istanbul, Turkey |
|---|
| 702 | -1 | $a Ozturk $b A. $3 sllk_un_auth*p0032318 $4 070 $p Department of medical oncology, GATA Haydarpasa training hospital, Istanbul, Turkey |
|---|
| 801 | -0 | $a SK $b BA006 $c 20030911 $g AACR2 |
|---|
